Abstract
Since the U.S. Food and Drug Administration (FDA) statement on mesh in July of 2011, there has been controversy regarding synthetic mesh repairs for vaginal prolapse. In this article, we review the biochemical basis for the use of synthetic mesh in prolapse repair as well as clinical results of anterior compartment prolapse repair with synthetic mesh. Finally, we discuss the FDA warning regarding mesh.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Tinelli A, Malvasi A, Rahimi S, et al. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women. Menopause. 2010.
Popovic JR, Kozak LJ. National hospital discharge survey: annual summary 1998. Vital Health Stat. 2000.
Olsen AL, Smith BJ, Bergstom JO, et al. Epidemiology of surgically managed POP and urinary incontinence. Ob Gyn. 1997.
• Vulic M, Stinic T, Bukovic D, et al. Expression of matrix metalloproteinase-1 in uterosacral ligaments tissue of women with genital prolapse. Coll Antropol. 2010. This paper reviews expression of MMP-1 in the uterosacral ligaments of patients with without prolapse and. In body mass index (BMI)-, age-, and parity-matched populations, the authors were able to show increased levels of MMP-1 (collagen degradation enzyme) in patients with prolapse.
Vulic M, Strinc T, Tomic, et al. Difference in expression of collagen type 1 and matrix metalloproteinase-1 in uterosacral ligaments of women with and without pelvic organ prolapse. Eur J Obstet Gynecol. 2011.
Liang CC, Huang HY, Tseng, et al. Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 in women with uterine prolapse but without urinary incontinence. Eur J Obstet Gynecol. 2010.
Takacs P, Nassiri M, Viciana A, et al. Fibulin-5 expression is decreased in women with anterior vaginal wall prolapse. Int Urogynecol. 2008
Yamamoto K, Yamamoto M, Akazawa K, et al. Decrease in elastin gene expression and protein synthesis in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int. 1997;21:605.
Moon YJ, Chori JR, Jeon MJ, et al. Alteration of elastin metabolism in women with pelvic organ prolapse. J Urol. 2011.
Boublil V, Ciofu C, Traxer O, et al. Complications of urethral sling procedures. Curr Opin Obstet Gynecol. 2002.
Karlovsjky ME, Tharke AA, Ardeshir R, et al. Biomaterials for pelvic floor reconstruction. J Urol. 2005.
Silva WA, Karram MM. Scientific basis for use of grafts during vaginal reconstructive procedures. Curr Opin Obstet Gynaecol. 2005.
Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol. 2008.
Sivasligolu AA, Unlubilgin E, Dolen I. A randomized comparison of polypropylene mesh surgery with site-specific surgery in treatment of cystocele. Int Urogynecol J Pelvic Floor Dysfunct. 2008.
•• Nieminen K, Hiltunen R, Takala T, et al. Outcomes after anterior vaginal wall repair with mesh: a randomized controlled trial with 4 year follow-up. Am J Obstet Gynecol. 2010. This randomized trial is described in the article as well as in table 1. This was a randomized trial of 200 patients who had anterior prolapse repairs with mesh or colporrhaphy. The mesh arm had improved anatomic outcomes but a 19 % vaginal mesh extrusion rate.
•• Altman D, Vayrynen T, Engh ME, et al. Anterior colporrhaphy versus transvaginal mesh for pelvic organ prolapse. N Engl J Med. 2011. This randomized trial is described in the article as well as in table 1. This was a randomized trial of 389 patients who had anterior prolapse repairs with mesh kit or colporrhaphy. The mesh arm had improved anatomic outcomes, but had a 3.2 % rate of vaginal mesh extrusion and a higher rate of dyspareunia (not statistically significant).
Al-Nazer MA, Ismail WA, Gomaa IA. Comparative study between anterior colporraphy versus vaginal wall repair with mesh for management of anterior vaginal wall prolapse (Abstract number 84). Int Urogynecol J Pelvic Floor Dysfunct. 2007;18 Suppl 1:49–50.
Ali S, Han HC, Lee LC. A prospective randomized trial using Gynemesh PS (trademark) for the repair of anterior vaginal wall prolapse (Abstract number 292). Int Urogynecol J Pelvic Floor Dysfunct. 2006;17 Suppl 2:221.
Lim JL, Carey MP, Higgs PJ, Goh J, Krause H, Leong A, et al. Vaginal colporrhaphy versus vaginal repair with mesh for pelvic organ prolapse: a randomised controlled trial (Abstract number 65). Int Urogynecol J Pelvic Floor Dysfunct. 2007;18 Suppl 1:38–9.
Feiner B, Jelovsek JE, Maher C. Efficacy and safety of transvaginal mesh kits in the treatment of prolapse of the vaginal apex: a systematic review. BJOG. 2009.
U.S. Food and Drug Administration. FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm262752.htm. Accessed March 2012.
Committee Opinion no 513: vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol. 2011;118(6):1459–64.
• Dietz HP, Erdmann M, Shek KL. Mesh contraction: myth or reality? Am J Obstet Gynecol. 2011;204(173):e1–4. In a study of 40 patients post–anterior prolapse repair with synthetic mesh (3–52 months postoperatively),the authors found no evidence of mesh contraction with ultrasound. In fact, they found that mesh length was increased.
Disclosures
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, B.N., Lucioni, A. & Kobashi, K.C. Anterior Pelvic Organ Prolapse Repair Using Synthetic Mesh. Curr Urol Rep 13, 211–215 (2012). https://doi.org/10.1007/s11934-012-0246-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-012-0246-0